XBiotech Inc (XBIT)
7.64
-0.12
(-1.55%)
USD |
NASDAQ |
Apr 30, 16:00
7.68
+0.04
(+0.52%)
After-Hours: 20:00
XBiotech 1 Year Total Returns (Daily): 122.1% for April 30, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 30, 2024 | 122.1% |
April 29, 2024 | 125.6% |
April 26, 2024 | 157.2% |
April 25, 2024 | 147.3% |
April 24, 2024 | 135.3% |
April 23, 2024 | 136.4% |
April 22, 2024 | 129.8% |
April 19, 2024 | 129.7% |
April 18, 2024 | 125.4% |
April 17, 2024 | 120.4% |
April 16, 2024 | 151.7% |
April 15, 2024 | 164.3% |
April 12, 2024 | 152.0% |
April 11, 2024 | 160.3% |
April 10, 2024 | 178.6% |
April 09, 2024 | 156.8% |
April 08, 2024 | 169.5% |
April 05, 2024 | 135.9% |
April 04, 2024 | 174.3% |
April 03, 2024 | 143.1% |
April 02, 2024 | 145.5% |
April 01, 2024 | 127.5% |
March 28, 2024 | 144.1% |
March 27, 2024 | 137.1% |
March 26, 2024 | 139.3% |
Date | Value |
---|---|
March 25, 2024 | 124.9% |
March 22, 2024 | 123.9% |
March 21, 2024 | 122.4% |
March 20, 2024 | 116.3% |
March 19, 2024 | 107.9% |
March 18, 2024 | 93.86% |
March 15, 2024 | 74.85% |
March 14, 2024 | 95.09% |
March 13, 2024 | 90.63% |
March 12, 2024 | 89.52% |
March 11, 2024 | 90.12% |
March 08, 2024 | 93.94% |
March 07, 2024 | 85.22% |
March 06, 2024 | 82.86% |
March 05, 2024 | 87.76% |
March 04, 2024 | 90.75% |
March 01, 2024 | 89.91% |
February 29, 2024 | 86.31% |
February 28, 2024 | 88.69% |
February 27, 2024 | 90.18% |
February 26, 2024 | 100.3% |
February 23, 2024 | 81.69% |
February 22, 2024 | 75.86% |
February 21, 2024 | 97.14% |
February 20, 2024 | 71.19% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-77.90%
Minimum
Nov 03 2022
371.0%
Maximum
Dec 09 2019
29.97%
Average
12.25%
Median
Aug 12 2021
1 Year Total Returns (Daily) Benchmarks
NovaBay Pharmaceuticals Inc | -92.97% |
Palatin Technologies Inc | -18.42% |
iBio Inc | -92.08% |
Theriva Biologics Inc | -36.11% |
Oragenics Inc | -63.04% |